Breathtec Biomedical (BTH) Stock Price, News & Analysis

Company Overview

Breathtec Biomedical, Inc., through its subsidiary, Nash Pharmaceuticals Inc., focuses on drug repurposing in the areas of non-alcoholic steatohepatitis, chronic kidney, and inflammatory bowel diseases. Its lead compound is the NP-178 for use in the treatment of ulcerative colitis. The company also develops NP-120 that is clinically used for the treatment of ulcerative colitis and Crohn's diseases. Breathtec Biomedical, Inc. is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 101,838 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BTH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Breathtec Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Breathtec Biomedical investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU).

Industry, Sector and Symbol

• Stock Exchange: AEX
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: AEX:BTH
• CIK: N/A
• Web: www.breathtecbiomedical.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A